<?xml version="1.0" encoding="UTF-8"?>
<p id="Par16">To validate the above results, we collected RBC and Hb data from 114 independent COVID-19 critical patients without selected comorbidities (51 survivors and 63 non-survivors). Consistently, RBC and Hb levels in critical survivors showed more significant fluctuation than critical non-survivors (Fig.Â 
 <xref rid="Fig3" ref-type="fig">3</xref>c), indicating that a progressive decline in erythrocytes may be related to prognosis in critical patients. Yet, the underlying mechanism of this potential correlation needs further investigation.
</p>
